Register entry
- Registered sites
- 1
- Active NDC listings
- 6
- Live patents
- 0
- Countries
- 1
- Base
- Hong Kong
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| ETERNAL WEALTH (CHINA) LIMITEDRegistrant: ETERNAL WEALTH CHINA LIMITED | Rm 1003 10/F LIPPO CTR TWR 1, 89 QUEENSWAY, Admiralty, , Hong Kong (HKG) | Active ingredient (API) manufacture | 3039067991655727273 |
Catalogue
Drug listings by form and route
66 active NDC listings: 6 bulk ingredient. By marketing category: BULK INGREDIENT 6.
| Dosage form | NDCs |
|---|---|
| powder | 6 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| eternal wealth(china)limited | 6 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | 5-Amino-1-methylquinolinium chloride | powder | 85793-005BULK INGREDIENT |
| - | ATX-304 | powder | 85793-006BULK INGREDIENT |
| - | Liraglutide | powder | 85793-002BULK INGREDIENT |
| - | ORFORGLIPRON | powder | 85793-003BULK INGREDIENT |
| - | ORFORGLIPRON CALCIUM | powder | 85793-004BULK INGREDIENT |
| - | Retatrutide | powder | 85793-001BULK INGREDIENT |
Enquiry
Common questions
- Is ETERNAL WEALTH CHINA LIMITED FDA approved?
- ETERNAL WEALTH CHINA LIMITED holds 1 FDA-registered establishment in Hong Kong. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are ETERNAL WEALTH CHINA LIMITED's drugs manufactured?
- The FDA register lists 89 QUEENSWAY. Registered operations: active ingredient (API) manufacture.
- What drugs does ETERNAL WEALTH CHINA LIMITED make?
- 6 products are listed under ETERNAL WEALTH CHINA LIMITED in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.